Potential Coronavirus Treatments Enter Large Clinical Trials | The Institute for Creation Research

Potential Coronavirus Treatments Enter Large Clinical Trials
Some good news in potential treatment options for COVID-19 was reported in the American journal Science.1 Four new treatment options were being tried in a large-scale study across multiple countries. Currently, about 15% of COVID-19 patients need to be treated in a hospital or similar setting and some facilities and staff are being swamped. Science reported,

The World Health Organization (WHO) announced a large global trial, called SOLIDARITY, to find out whether any can treat infections with the new coronavirus for the dangerous respiratory disease. It’s an unprecedented effort—an all-out, coordinated push to collect robust scientific data rapidly during a pandemic. The study, which could include many thousands of patients in dozens of countries, has been designed to be as simple as possible so that even hospitals overwhelmed by an onslaught of COVID-19 patients can participate.1

What is remarkable is that so much political red tape was surmounted so quickly. In fact, this trial has a similar European counterpart, called Discovery, that will include patients from France, Spain, the United Kingdom, Germany, and the Benelux countries. These trials aim to discover as quickly as possible what does and does not work. They are using existing drugs with a familiar track record for safety and efficacy against other viral diseases bearing some similarities to COVID-19.

The drugs being tried include the following: the anti-malarial drugs chloroquine and hydroxychloroquine, the antiviral drug remdesivir, a ritonavir/lopinavir combination, and ritonavir/lopinavir in conjunction with interferon-beta (a molecule involved in regulating immune responses in the body).

No timeline was reported as to when results would be forthcoming. But, it is possible that some initial findings might even give indications of efficacy. These will likely be shared with the medical community and the public at large.

Getting so many politicians, bureaucrats, and clinicians to align for a common purpose so quickly could elicit the exclamation, “That’s a miracle!” Perhaps these clinical trials are an answer to prayer, since “The king’s heart is in the hand of the Lord, like the rivers of water; He turns it wherever He wishes.”2

References
1. Kupferschmidt, K. and J. Cohen. 2020. WHO launches global megatrial of the four most promising coronavirus treatments. Science. Posted on sciencemag.org March 22, 2020, accessed March 25, 2020.
2. Proverbs 21:1.

*Randy Guliuzza is ICR’s National Representative. He earned his Doctor of Medicine from the University of Minnesota, his Master of Public Health from Harvard University, and served in the U.S. Air Force as 28th Bomb Wing Flight Surgeon and Chief of Aerospace Medicine. Dr. Guliuzza is also a registered Professional Engineer.
The Latest
NEWS
Liberty and the Word of God
“And I will walk at liberty: for I seek thy precepts” (Psalm 119:45). July 4th is called Independence Day here in our country because on...

NEWS
July 2025 ICR Wallpaper
"These things I have spoken to you, that in Me you may have peace. In the world you will have tribulation; but be of good cheer, I have overcome...

NEWS
Valued Longtime ICR Employee Mary Smith Retires
Mary Morris Smith, an employee of the Institute for Creation Research for many years, has retired. The second daughter of ICR founder Dr. Henry M. Morris...

NEWS
Man of Science, Man of God: George Washington Carver
Who:  George Washington Carver What: Father of Modern Agriculture When: 1864 or 1865 – January 5, 1943 Where: Diamond Grove,...

ACTS & FACTS
The Scopes Monkey Trial: A Battle of Worldviews
Rhea County Courthouse in Dayton, Tennessee, and its statue of William Jennings Bryan Image credit: M. Mueller The Scopes Monkey...

ACTS & FACTS
Long Non-Coding RNAs: The Unsung Heroes of the Genome
Evolutionary theory holds that all living things came about through random, natural processes. So conventional scientists believe the genome has developed...

ACTS & FACTS
Yosemite National Park, Part 1: Tiny Clues of a Grand Picture
Yosemite National Park in California is a sure source of stunning scenery. It’s no wonder that American naturalist John Muir persuaded President...

ACTS & FACTS
From Inference to Theory: A Common Design Case Study
Without a doubt, humans, chimpanzees, and other organisms share similar features. An early explanation was that these features reflect similar designs...

ACTS & FACTS
Creation Kids: T. rex
by Michael Stamp and Susan Windsor* You're never too young to be a creation scientist and explore our Creator's world. Kids, discover...

ACTS & FACTS
Entering By The Door
Recently, I hosted a visiting pastor from a large church at ICR’s Discovery Center. As I guided him through our Dallas museum, one conversation...